ZBD's compound Qindan oral liquid drug clinical trial has been approved
I'm LongbridgeAI, I can summarize articles.According to the Zhontong Finance APP, ZBD announced that the company has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The drug name is: Compound Qilan Oral Solution. The approval conclusion is: The clinical trial application for Compound Qilan Oral Solution (CYZB2500437) accepted on March 13, 2025, meets the relevant requirements for drug registration. Based on further improvement of the clinical trial protocol, the product is approved to conduct clinical trials for the treatment of exogenous wind-heat in children aged 4-12
According to the Zhitong Finance APP, ZBD (603567.SH) announced that the company has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration. The drug name is: Compound Qilan Oral Solution. The approval conclusion is: The clinical trial application for Compound Qilan Oral Solution (CYZB2500437) accepted on March 13, 2025, meets the relevant requirements for drug registration. Based on further improvement of the clinical trial protocol, the product is approved to conduct clinical trials for the treatment of exogenous wind-heat in children aged 4-12